Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

Cambridge Nutritional Sciences plc

Healthcare GB CNSL

1.85GBX
0.00(0%)

Last update at 2026-06-05T14:59:00Z

Day Range

1.731.90
LowHigh

52 Week Range

1.704.33
LowHigh

Fundamentals

  • Previous Close 1.85
  • Market Cap4.40M
  • Volume91139
  • P/E Ratio1.85
  • Dividend Yield-%
  • EBITDA-0.32600M
  • Revenue TTM8.06M
  • Revenue Per Share TTM0.03
  • Gross Profit TTM 5.35M
  • Diluted EPS TTM0.01

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Income before tax 1.57M -0.74500M -3.25200M -0.95000M -0.54600M
Minority interest - - - - -
Net income 1.57M -0.32800M -3.86000M -11.33300M -2.10400M
Selling general administrative 6.12M 5.29M 4.75M 4.44M 3.64M
Selling and marketing expenses - 1.38M 1.53M 1.26M 0.98M
Gross profit 5.00M 6.05M 3.17M 4.75M 4.00M
Reconciled depreciation 0.61M 0.65M 0.59M 1.29M -
Ebit 1.58M -0.72300M -3.23900M -0.92900M -0.46800M
Ebitda 2.20M -0.07300M -2.64800M -0.38200M 0.42M
Depreciation and amortization 0.61M 0.65M 0.59M 0.55M 0.89M
Non operating income net other - - - - -
Operating income -0.64000M -0.53500M -2.77900M -0.58200M -0.48800M
Other operating expenses 8.97M 10.31M 10.32M 9.13M 7.28M
Interest expense 0.02M 0.02M 0.01M 0.02M 0.08M
Tax provision 0.00000M -0.41700M -0.08000M 0.46M -
Interest income 0.15M 0.05M 0.00000M - -
Net interest income 0.13M 0.03M -0.01300M -0.02100M -
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - -0.41700M -0.08000M 0.46M -0.93100M
Total revenue 8.33M 9.77M 7.55M 8.54M 6.82M
Total operating expenses 5.64M 6.58M 5.95M 5.33M 4.28M
Cost of revenue 3.33M 3.73M 4.37M 3.79M 2.82M
Total other income expense net 2.21M -0.21000M -0.47300M -0.35800M -0.07800M
Discontinued operations - - - - -
Net income from continuing ops 1.57M -0.32800M -3.17200M -1.40900M -
Net income applicable to common shares - - - - -
Preferred stock and other adjustments - - - - -
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Total assets 13.80M 13.89M 14.40M 17.84M 29.55M
Intangible assets 0.80M 1.08M 1.51M 1.73M 6.88M
Earning assets - - - - -
Other current assets 0.20M 0.12M 0.07M 5.20M 0.13M
Total liab 2.39M 4.21M 4.45M 6.02M 6.16M
Total stockholder equity 11.41M 9.68M 9.95M 11.82M 23.38M
Deferred long term liab - - - - -
Other current liab 1.13M 0.83M 0.97M 2.40M 1.26M
Common stock 10.26M 10.26M 10.24M 8.04M 8.03M
Capital stock 10.26M 10.26M 10.24M 8.04M -
Retained earnings -23.83300M -25.58500M -25.31900M -21.53700M -9.89100M
Other liab - - - - -
Good will 3.02M 3.02M 3.02M 3.02M 3.02M
Other assets - - - - -
Cash 4.87M 2.94M 5.12M 1.60M 5.83M
Cash and equivalents - - - - -
Total current liabilities 2.12M 1.69M 1.94M 3.44M 3.05M
Current deferred revenue - - - - -
Net debt -4.51900M -2.79500M -5.04100M -1.23500M -2.98400M
Short term debt 0.22M 0.25M 0.11M 0.59M 0.76M
Short long term debt - - - - -
Short long term debt total 0.35M 0.15M 0.07M 0.37M 2.84M
Other stockholder equity 25.07M 25.01M 25.03M 25.31M 25.29M
Property plant equipment - - - - -
Total current assets 7.66M 7.88M 8.29M 10.74M 12.24M
Long term investments - - - - -
Net tangible assets - - - - -
Short term investments - 2.50M - - -
Net receivables 1.77M 1.70M 2.33M 2.84M 4.04M
Long term debt - - - - -
Inventory 0.83M 0.61M 0.78M 1.09M 2.24M
Accounts payable 0.77M 0.61M 0.85M 0.45M 1.03M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -0.08500M - - - -0.04100M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - -
Deferred long term asset charges - - - - -
Non current assets total 6.14M 6.02M 6.11M 7.10M 17.31M
Capital lease obligations 0.35M 0.15M 0.07M 0.37M -
Long term debt total - - - - -
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Investments 2.50M -2.50100M 0.00000M - -
Change to liabilities - - - - -
Total cashflows from investing activities 2.12M -2.51000M 5.18M -0.49300M -2.82500M
Net borrowings -0.14000M -0.14300M -0.31400M 0.00000M -
Total cash from financing activities -0.25100M -0.26500M 1.49M -0.50200M 11.07M
Change to operating activities - - - - -
Net income 1.57M -0.32800M -3.86000M -11.33300M -2.10400M
Change in cash 1.93M -2.17200M 3.51M -4.22200M 5.83M
Begin period cash flow 2.94M 5.12M 1.60M 5.83M -
End period cash flow 4.87M 2.94M 5.12M 1.60M 5.83M
Total cash from operating activities 0.08M 0.61M -3.15200M -3.22900M -2.41900M
Issuance of capital stock - 0.00000M 2.20M 0.07M -
Depreciation 0.61M 0.65M 0.59M 1.29M 0.89M
Other cashflows from investing activities -0.00100M 0.04M -0.10900M - -0.86000M
Dividends paid - - - - -
Change to inventory -0.22200M 0.17M 0.13M 0.48M -1.06900M
Change to account receivables -0.14100M 0.58M 0.81M 1.13M -0.88700M
Sale purchase of stock - - - - -
Other cashflows from financing activities -0.11100M -0.12200M -0.40000M -0.37200M -0.21800M
Change to netincome - - - - -
Capital expenditures 0.22M 0.06M 0.15M 1.48M 2.83M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -2.29400M 0.55M -0.66500M 1.47M -0.88400M
Stock based compensation 0.19M 0.07M 0.08M 0.28M 0.27M
Other non cash items 0.20M -0.33500M 0.70M 5.07M -0.58700M
Free cash flow -0.14200M 0.55M -3.30500M -4.70700M -5.24400M

Peer Comparison

Sector: Healthcare Industry: Medical Instruments & Supplies

Company Change (GBX) Price (GBX) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
CNSL
Cambridge Nutritional Sciences plc		 - -% 1.85 1.85 99.01 0.55 0.40 0.13 0.52
CTEC
ConvaTec Group PLC		 - -% 204.20 37.27 14.66 1.79 3.77 2.94 13.89
AMS
Advanced Medical Solutions Group plc		 -4.0 1.81% 217.00 40.60 16.84 1.92 1.66 2.16 11.16
TSTL
Tristel		 5.00 1.33% 380.00 23.75 19.08 3.68 5.29 3.43 13.18
SPEC
Inspecs Group plc		 - -% 84.50 - 16.16 0.43 0.95 0.62 7.94

Reports Covered

Stock Research & News

View All

Profile

Cambridge Nutritional Sciences plc, together with its subsidiaries, develops, manufactures, and distributes medical diagnostics products for the food sensitivity testing market. The company is involved in the research, development, and production of kits for detection of immune reactions to food under the FoodPrint brand. It also provides clinical analysis to the general public, clinics, and health professionals; and supplies Food Detective, a food sensitivity test. In addition, the company offers My Health Tracker, a health app for tracking symptoms, accessing FoodPrint results, and managing gut health; and CNS Lab, which provides laboratory services for food sensitivity. It serves the government, private hospitals and clinics, reference laboratories, nutritionists, naturopaths, consumers, and functional medicine healthcare practitioners in the United Kingdom, rest of Europe, North America, South/Central America, India, rest of Asia and the Far East, Africa, and the Middle East. The company was formerly known as Omega Diagnostics Group PLC and changed its name to Cambridge Nutritional Sciences plc in September 2023. Cambridge Nutritional Sciences plc is based in London, the United Kingdom.

Cambridge Nutritional Sciences plc

One Fleet Place, London, United Kingdom, EC4M 7WS

Key Executives

Name Title Year Born
Mr. James Cooper B.A., M.Sc. CEO & Executive Director 1991
Mr. Ajay Patel A.C.A., L.L.B. CFO, Secretary & Executive Director 1964
Mr. Iain Alexander James Logan Group Financial Controller 1973
Mr. Prashant Maniar Managing Director of Omega Dx Asia Pvt Limited NA
Motunrayo Oyegunle Secretary NA
Mr. Andrew William Shepherd BSc.(Hons) Global Ambassador - Life President 1956

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions